These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33512605)

  • 21. Long-Term Outcome After Ventricular Tachycardia Ablation in Nonischemic Cardiomyopathy: Late Potential Abolition and VT Noninducibility.
    Okubo K; Gigli L; Trevisi N; Foppoli L; Radinovic A; Bisceglia C; Frontera A; D'Angelo G; Cireddu M; Paglino G; Mazzone P; Della Bella P
    Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008307. PubMed ID: 32657137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy: A propensity score-matched analysis of in-hospital outcomes in the United States.
    Briceño DF; Gupta T; Romero J; Kolte D; Khera S; Villablanca PA; Tran A; Mohanty S; Trivedi C; Mohanty P; Gianni C; Kim SG; Garcia M; Fonarow GC; Bhatt DL; Natale A; Di Biase L
    J Cardiovasc Electrophysiol; 2018 May; 29(5):771-779. PubMed ID: 29399923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy with near-normal left ventricular ejection fraction.
    Bennett RG; Campbell T; Kotake Y; Turnbull S; Kumar S
    Heart Rhythm; 2022 Jan; 19(1):51-60. PubMed ID: 34597769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study.
    Dinov B; Fiedler L; Schönbauer R; Bollmann A; Rolf S; Piorkowski C; Hindricks G; Arya A
    Circulation; 2014 Feb; 129(7):728-36. PubMed ID: 24211823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia.
    Komatsu Y; Daly M; Sacher F; Cochet H; Denis A; Derval N; Jesel L; Zellerhoff S; Lim HS; Jadidi A; Nault I; Shah A; Roten L; Pascale P; Scherr D; Aurillac-Lavignolle V; Hocini M; Haïssaguerre M; Jaïs P
    J Am Coll Cardiol; 2014 Apr; 63(14):1416-26. PubMed ID: 24486269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epicardial ventricular tachycardia in ischemic cardiomyopathy: Prevalence, electrophysiological characteristics, and long-term ablation outcomes.
    Hayashi T; Liang JJ; Muser D; Shirai Y; Enriquez A; Garcia FC; Supple GE; Schaller RD; Frankel DS; Lin D; Nazarian S; Zado ES; Arkles JS; Dixit S; Callans DJ; Marchlinski FE; Santangeli P
    J Cardiovasc Electrophysiol; 2018 Nov; 29(11):1530-1539. PubMed ID: 30230120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome.
    Proietti R; Essebag V; Beardsall J; Hache P; Pantano A; Wulffhart Z; Juta R; Tsang B; Joza J; Nascimento T; Pegoraro V; Khaykin Y; Verma A
    Europace; 2015 Mar; 17(3):461-7. PubMed ID: 25488957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined endo- and epicardial pace-mapping to localize ventricular tachycardia isthmus in ischaemic and non-ischaemic cardiomyopathy.
    Hanaki Y; Komatsu Y; Nogami A; Kowase S; Kurosaki K; Sekiguchi Y; Aonuma K; Ieda M
    Europace; 2022 Apr; 24(4):587-597. PubMed ID: 34543395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction and prognosis of ventricular tachycardia recurrence after catheter ablation with remote magnetic navigation for electrical storm in patients with ischemic cardiomyopathy.
    Jin Q; Jacobsen PK; Pehrson S; Chen X
    Clin Cardiol; 2017 Nov; 40(11):1083-1089. PubMed ID: 28817194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dexmedetomidine for sedation during epicardial ablation for ventricular tachycardia: a single-center experience.
    Conti S; Sabatino F; Cascino A; Ferrara G; Sgarito G
    J Interv Card Electrophysiol; 2023 Jan; 66(1):79-85. PubMed ID: 36018425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relevance of Chronic Total Occlusion for Outcome of Ventricular Tachycardia Ablation in Ischemic Cardiomyopathy.
    Lurz JA; Schmidt E; Kresoja KP; Torri F; König S; Darma A; Arya A; Bertagnolli L; Hindricks G; Dinov B
    J Interv Cardiol; 2022; 2022():6829725. PubMed ID: 35935125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implantable cardioverter defibrillator therapy in patients with ischemic or non-ischemic cardiomyopathy and nonsustained ventricular tachycardia.
    Evonich RF; Maheshwari A; Gardiner JC; Khasnis A; Kantipudi S; Ip JH; Grimes D; Hayter G; Thakur RK
    J Interv Card Electrophysiol; 2004 Aug; 11(1):59-65. PubMed ID: 15273456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death.
    Amara N; Boveda S; Defaye P; Klug D; Treguer F; Amet D; Perier MC; Gras D; Algalarrondo V; Bouzeman A; Piot O; Deharo JC; Fauchier L; Babuty D; Bordachar P; Sadoul N; Marijon E; Leclercq C;
    Europace; 2018 Jan; 20(1):65-72. PubMed ID: 28082419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial experience of temperature-controlled irrigated radiofrequency ablation for ischaemic cardiomyopathy ventricular tachycardia ablation.
    Al-Sheikhli J; Patchett I; Lim VG; Marshall L; Foster W; Kuehl M; Yusuf S; Panikker S; Patel K; Osman F; Banerjee P; Lellouche N; Dhanjal T
    J Interv Card Electrophysiol; 2023 Apr; 66(3):551-559. PubMed ID: 35192098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contemporary approach to catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy.
    Kattel S; Enriquez AD
    J Interv Card Electrophysiol; 2023 Apr; 66(3):793-805. PubMed ID: 36056222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First-line ablation of ventricular tachycardia in ischemic cardiomyopathy: stratification of outcomes by left ventricular function.
    Briceño DF; Romero J; Patel K; Liaqat W; Zhang XD; Alviz I; Yang R; Rodriguez D; Lakkireddy D; Rocca DD; Tarantino N; Gopinathannair R; Natale A; Di Biase L
    J Interv Card Electrophysiol; 2021 Nov; 62(2):391-400. PubMed ID: 33179155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Comparison of Women and Men Undergoing Catheter Ablation for Sustained Monomorphic Ventricular Tachycardia.
    Baldinger SH; Kumar S; Romero J; Fujii A; Epstein LM; Michaud GF; John R; Tedrow UB; Stevenson WG
    J Cardiovasc Electrophysiol; 2017 Feb; 28(2):201-207. PubMed ID: 27860063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of ventricular tachyarrhythmias and their susceptibility to antitachycardia pacing termination in patients with ischemic and nonischemic cardiomyopathy: A patient-level meta-analysis of three large clinical trials.
    Cheng A; Joung B; Brown ML; Koehler J; Lexcen DR; Sanders P; Ellenbogen KA
    J Cardiovasc Electrophysiol; 2020 Oct; 31(10):2720-2726. PubMed ID: 32700390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of catheter ablation for ventricular tachycardia in patients with ischemic cardiomyopathy: A systematic review and meta-analysis of randomized clinical trials.
    Maskoun W; Saad M; Abualsuod A; Nairooz R; Miller JM
    Int J Cardiol; 2018 Sep; 267():107-113. PubMed ID: 29655948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of simultaneous unipolar radiofrequency catheter ablation for intramural septal ventricular tachycardia in nonischemic cardiomyopathy.
    Yang J; Liang J; Shirai Y; Muser D; Garcia FC; Callans DJ; Marchlinski FE; Santangeli P
    Heart Rhythm; 2019 Jun; 16(6):863-870. PubMed ID: 30576879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.